fbpx

Strategies for diabetes and obesity prevention and management

Table of Contents

Confronting the Diabetes and Obesity Epidemic: Strategies for Prevention and Management

Introduction

The global prevalence of diabetes and obesity has reached alarming proportions, posing a major public health challenge to societies worldwide.

According to the World Health Organization (WHO), approximately 422 million people suffer from diabetes, while more than 1.9 billion adults are overweight, with over 650 million classified as obese[1]. 

These staggering numbers indicate an urgent need for comprehensive strategies to prevent and manage both diabetes and obesity. This article aims to address this pressing issue by exploring various approaches to confront the diabetes and obesity epidemic, as outlined in the following sections.

Diabetes and obesity are closely linked, with obesity being a significant risk factor for the development of type 2 diabetes. In fact, nearly 90% of individuals diagnosed with type 2 diabetes are overweight or obese[2]. 

A global imperative

Adopting evidence-based strategies for prevention and management

This connection underscores the importance of understanding the complexities of both conditions and identifying effective prevention and management strategies. 

Preventing diabetes and obesity requires promoting healthy eating habits, increasing physical activity, and implementing early identification and intervention strategies. Public health campaigns play a crucial role in educating individuals about the benefits of a balanced diet, portion control, and regular exercise[3]. 

Once diagnosed, managing diabetes and obesity necessitates a combination of medical treatments, lifestyle modifications, and continuous monitoring of progress. Advances in technology have greatly facilitated self-monitoring and personalized care, enabling patients to better manage their conditions[4]. 

Healthcare professionals, government agencies, and non-profit organizations collaborate to ensure the most effective interventions are implemented and continually refined.

Significantly reduce the human and economic burden of these conditions[5]. The time for action is now, on the health and well-being of millions of people around the world.

Understanding diabetes and obesity

Factors and tailoring interventions to individual needs

Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to impaired insulin production or action. 

There are two main types of diabetes: type 1, which results from an autoimmune destruction of insulin-producing beta cells in the pancreas, and type 2, which arises from a combination of insulin resistance and inadequate insulin secretion[6]. 

Type 2 diabetes is the most common form, accounting for approximately 90-95% of cases[7]. 

Obesity, defined as a body mass index (BMI) of 30 or higher, is a significant risk factor for the development of type 2 diabetes, with nearly 90% of individuals diagnosed with type 2 diabetes being overweight or obese[2].

A multifaceted approach that acknowledges the role of genetics, environmental factors, and lifestyle choices in the development of diabetes and obesity can provide a foundation for evidence-based prevention and management strategies. 

Significant strides in reducing the burden of diabetes and obesity on both individuals and society.

Underpinning the obesity-diabetes connection

The link between obesity and diabetes strategies

Excess adipose tissue, particularly in the abdominal region, is known to cause systemic inflammation and release of pro-inflammatory cytokines, which can impair insulin signaling and promote insulin resistance[8]. 

Obesity can lead to ectopic fat deposition in organs such as the liver and skeletal muscles, impairing their ability to respond to insulin and contributing to the development of type 2 diabetes[9].

Risk factors for diabetes and obesity are multifaceted, encompassing genetic, environmental, and lifestyle aspects. Genetic predisposition plays a role in both conditions, with certain gene variants increasing an individual’s susceptibility to obesity and type 2 diabetes[10]. 

Environmental and lifestyle factors are critical determinants of their development. Sedentary behavior, poor diet, and inadequate physical activity are all significant contributors to the rising prevalence of obesity and type 2 diabetes[11]. 

Socioeconomic factors such as income, education, and access to healthy foods and safe spaces for physical activity can influence the risk of developing these conditions[12].

Key to preventing and managing diabetes and obesity

Early identification and intervention diabetes

Recognizing and addressing the modifiable risk factors for diabetes and obesity is crucial in developing effective prevention and management strategies.

Encouraging healthier eating habits, such as consuming a balanced diet rich in whole foods and low in processed, energy-dense foods, can help reduce the risk of obesity and its associated complications[3]. 

Engaging in regular physical activity has been shown to improve insulin sensitivity and reduce the risk of type 2 diabetes[13].

These preventive measures can significantly impact the trajectory of these conditions and help avert their long-term consequences.

Strategies for prevention

Effective prevention strategies for diabetes and obesity

It require a multi-pronged approach that addresses the complex interplay of modifiable risk factors, including diet, physical activity, and early intervention. Targeting these areas, we can significantly reduce the incidence of diabetes and obesity, thereby improving overall public health outcomes.

Promoting healthy eating habits

  • Educating the public on nutrition and portion control:

    Empowering individuals with knowledge about proper nutrition and portion sizes is essential in promoting healthier eating habits[14]. Public health campaigns and educational programs can play a vital role in disseminating accurate and actionable information about balanced diets and the dangers of overconsumption of processed, energy-dense foods.

Consumption of whole foods and reducing processed foods:

Consumption of whole foods, such as fruits, vegetables, whole grains, and lean proteins, has been shown to reduce the risk of obesity and type 2 diabetes[15].

Public health initiatives should focus on making whole foods more accessible and affordable, while simultaneously discouraging the consumption of processed foods high in sugar, unhealthy fats, and sodium.

Increasing physical activity

  • Creating accessible public spaces for exercise:

    The availability of safe and accessible public spaces for physical activity is crucial in promoting active lifestyles. Urban planning and policy measures should prioritize the development of parks, walking and biking paths, and recreational facilities to encourage community engagement in physical activity[16].
  • Encouraging schools and workplaces to promote physical activity:

    Schools and workplaces play a significant role in shaping daily routines and habits. Implementing physical education programs in schools, offering flexible work hours to accommodate exercise, and providing on-site fitness facilities can help promote regular physical activity among students and employees[17].

Early identification and intervention

  • Regular health screenings:

    Routine health screenings can aid in the early identification of risk factors for diabetes and obesity, such as elevated blood sugar levels, high blood pressure, and abnormal cholesterol levels[18]. Early detection and intervention can significantly reduce the risk of developing these conditions and enable individuals to adopt healthier lifestyles.

  • Identifying at-risk individuals and providing targeted support:

    Healthcare providers and public health officials should prioritize identifying individuals at a higher risk of developing diabetes and obesity, based on factors such as family history, BMI, and lifestyle habits. Targeted support, including nutritional counseling, exercise programs, and access to healthcare resources, can help these individuals make lasting lifestyle changes and reduce their risk of developing diabetes and obesity[19].

Collaborative efforts among healthcare professionals, government agencies, and non-profit organizations can significantly impact the trajectory of these conditions and improve the overall health and well-being of affected individuals and communities.

Medical treatments

  • Pharmacological interventions:

    A range of medications are available to manage diabetes, including insulin, oral hypoglycemic agents, and injectable non-insulin medications[20]. The choice of treatment depends on the type and severity of diabetes, as well as the individual patient’s needs and preferences. For obesity management, weight loss medications can be prescribed for certain individuals, in conjunction with lifestyle changes, to help achieve and maintain a healthier weight[21].
  • Bariatric surgery:

    For individuals with severe obesity and related health complications, bariatric surgery may be considered as a treatment option[22]. Bariatric surgery has been shown to result in significant weight loss and improvement in obesity-related comorbidities, including type 2 diabetes[23]. However, it is important to carefully evaluate the potential risks and benefits of surgery, and to provide ongoing support and monitoring post-surgery.

Lifestyle modifications

  • Nutrition and dietary counseling:

    Medical nutrition therapy, which involves individualized dietary counseling and meal planning, is a critical component of diabetes and obesity management[24]. Healthcare providers should work closely with patients to develop tailored nutrition plans that accommodate personal preferences, cultural backgrounds, and specific health needs.

  • Physical activity and exercise:

    Engaging in regular physical activity and exercise can help improve insulin sensitivity, promote weight loss, and enhance overall well-being for individuals with diabetes and obesity[25]. Healthcare providers should encourage patients to incorporate physical activity into their daily routines and provide guidance on safe and appropriate exercise regimens.

Continuous monitoring and support

Management of diabetes and obesity

Requires a personalized and comprehensive approach, incorporating medical treatments, lifestyle modifications, and ongoing support. Collaboration among healthcare professionals, patients, and their families, we can significantly improve the quality of life and overall health outcomes for individuals affected by these conditions.

  • Self-monitoring of blood glucose:

    For individuals with diabetes, regular self-monitoring of blood glucose levels is essential for effective management and adjustment of treatment plans[26]. Technological advancements, such as continuous glucose monitoring systems, have facilitated more accurate and convenient self-monitoring, allowing for better individualized care.

  • Behavioral and psychological support:

    Managing diabetes and obesity can be challenging, and providing behavioral and psychological support is crucial for long-term success. Access to support groups, counseling, and stress management resources can help individuals cope with the emotional aspects of managing their conditions and promote lasting lifestyle changes[27].

Continuous monitoring and support

  • Self-monitoring of blood glucose:

    For individuals with diabetes, regular self-monitoring of blood glucose levels is essential for effective management and adjustment of treatment plans[26]. Technological advancements, such as continuous glucose monitoring systems, have facilitated more accurate and convenient self-monitoring, allowing for better individualized care.

  • Behavioral and psychological support:

    Managing diabetes and obesity can be challenging, and providing behavioral and psychological support is crucial for long-term success. Access to support groups, counseling, and stress management resources can help individuals cope with the emotional aspects of managing their conditions and promote lasting lifestyle changes[27].

The role of government and public policy

Governments and public policy play a crucial role in addressing the diabetes and obesity epidemic. Enacting policies that promote healthy environments and behaviors, governments can help mitigate the risks and consequences associated with these conditions. 

Food policy and regulation

  • Food labeling and marketing:

Implementing clear and informative food labeling, such as calorie counts and nutritional information, can help consumers make healthier food choices[28]. Regulating the marketing and advertising of unhealthy foods, particularly to children, can also reduce the consumption of high-calorie, low-nutrient products[29].

  • Taxation and subsidies:

Governments can use fiscal measures, such as taxation on sugar-sweetened beverages and unhealthy foods, to discourage their consumption[30]. Conversely, subsidies for healthier food options can make them more affordable and accessible, thereby promoting healthier diets.

  • Walkability and active transportation:

Urban planning policies that prioritize walkability and active transportation can encourage physical activity, reducing the risk of obesity and diabetes[31]. This includes investments in pedestrian and bicycle infrastructure, such as sidewalks, bike lanes, and green spaces.

  • Access to healthy food options:

Policies that promote the availability and accessibility of healthy food options in underserved areas can help combat food deserts and improve overall nutrition[32]. This can be achieved through zoning regulations, incentives for grocery stores, and the establishment of community gardens and farmers’ markets.

Healthcare and prevention programs

  • Universal access to healthcare:

    Ensuring that all individuals have access to healthcare services, including screening, prevention, and management of diabetes and obesity, is essential for addressing these conditions on a population level[33]. Governments can work to expand healthcare coverage and reduce barriers to care, such as cost and geographic limitations.
  • Public health campaigns and education:

    Public health campaigns, such as those promoting healthy eating and physical activity, can raise awareness of diabetes and obesity risks and encourage healthier behaviors[34]. Providing education and resources to schools, workplaces, and communities can further support these efforts.

Research and innovation

The importance of collaborative efforts

  • Funding for research:

    Government investments in research can help advance our understanding of the causes, prevention, and treatment of diabetes and obesity[35]. This includes research into the genetic, environmental, and social determinants of these conditions, as well as the development of new interventions and therapies.

  • Promoting innovation and technology:

    Governments can support the development and implementation of innovative technologies, such as telehealth and mobile health applications, to improve the delivery of care and self-management for individuals with diabetes and obesity[36].

Addressing the diabetes and obesity epidemic requires a coordinated and collaborative effort among multiple stakeholders, including healthcare providers, researchers, government agencies, non-governmental organizations, and communities. This section highlights the importance of cross-sectoral collaboration and provides examples of successful initiatives that have improved the prevention and management of diabetes and obesity.

Healthcare providers and interdisciplinary teams

  • Integrated care models:

    Integrated care models that involve multidisciplinary teams of healthcare providers, such as physicians, dietitians, nurses, and mental health professionals, can deliver more comprehensive and effective care for individuals with diabetes and obesity[37]. Collaborative care can help address the complex needs of patients and improve health outcomes by fostering better communication, coordination, and shared decision-making.

  • Provider training and education:

    Ensuring that healthcare providers receive ongoing education and training in diabetes and obesity management can promote the adoption of evidence-based practices and improve patient care[38]. This includes training in culturally competent care, which is essential for addressing health disparities and providing equitable care to diverse populations.

Research partnerships

  • Translational research:

    Collaborations between researchers and healthcare providers can facilitate the translation of research findings into clinical practice, bridging the gap between scientific discovery and patient care[39]. Engaging patients in research as partners can also help ensure that the research is relevant and patient-centered.

  • Data sharing and collaboration:

    Sharing research data and resources among institutions and researchers can accelerate the pace of discovery and facilitate the development of new prevention and treatment strategies for diabetes and obesity[40]. This includes collaborations between academia, industry, and government, as well as international research partnerships.

Government and community involvement

Public-private partnerships

  • Policy advocacy:

    Partnerships among healthcare organizations, professional societies, and advocacy groups can help shape public policy and drive changes that promote the prevention and management of diabetes and obesity[41]. These collaborations can raise awareness, influence policy decisions, and ensure that the needs of affected individuals are considered in policy making.

  • Community-based interventions:

    Collaborative efforts between healthcare providers, community organizations, and local governments can create tailored, community-based interventions that address the specific needs and cultural contexts of diverse populations[42]. These initiatives can improve access to care, promote healthier environments, and engage communities in the prevention and management of diabetes and obesity.

  • Funding and resource allocation:

    Public-private partnerships can provide funding and resources for research, education, and community-based initiatives, leveraging the strengths of both sectors to address the diabetes and obesity epidemic[43]. These partnerships can foster innovation, enhance the scalability of successful interventions, and promote the long-term sustainability of programs.

  • Collaboration on innovative solutions:

    Public-private partnerships can also collaborate on the development and implementation of innovative solutions, such as digital health technologies and mobile applications, to improve the prevention and management of diabetes and obesity[44]. These collaborations can help ensure that technologies are accessible, user-friendly, and effective in addressing the needs of diverse populations.

Conclusion

In conclusion, confronting the diabetes and obesity epidemic requires a comprehensive and multi-sectoral approach, encompassing prevention and management strategies, the involvement of government and public policy, and the collaboration of various stakeholders.

The complex interplay between diabetes and obesity, we can identify evidence-based strategies for prevention, such as promoting healthy lifestyles and creating supportive environments[31]. 

Management approaches, including personalized care and the use of innovative technologies, can improve health outcomes for individuals living with these conditions[36].

Role of government and public policy is crucial in shaping the context in which prevention and management efforts take place[34]. Collaborative efforts among healthcare providers, researchers, government agencies, and communities are essential for creating a unified response to the epidemic[37]. 

Ultimately, the challenge of addressing the diabetes and obesity epidemic requires the commitment and concerted action of all sectors of society. 

Working together, we can create a healthier future for all, reducing the burden of these conditions on individuals, communities, and healthcare systems[42].

References

  1. World Health Organization. (2021). Diabetes. Retrieved from https://www.who.int/news-room/fact-sheets/detail/diabetes
  2. American Diabetes Association. (2018). Obesity management for the treatment of type 2 diabetes. Diabetes Care, 41(Supplement 1), S86-S104.
  3. Mozaffarian, D., Afshin, A., Benowitz, N. L., Bittner, V., Daniels, S. R., Franch, H. A., … & Huffman, M. D. (2012). Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation, 126(12), 1514-1563.
  4. Klonoff, D. C., & Zimmet, P. (2018). New technology for managing diabetes and obesity: can the epidemic be halted? The Lancet Diabetes & Endocrinology, 6(2), 85-87.
  5. Sagner, M., Katz, D., Egger, G., Lianov, L., Schulz, K. H., Braman, M., … & Ornish, D. (2014). Lifestyle medicine potential for reversing a world of chronic disease epidemics: from cell to community. International Journal of Clinical Practice, 68(11), 1289-1292.https://pubmed.ncbi.nlm.nih.gov/25348380/
  6. American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Supplement 1), S81-S90.
  7. Centers for Disease Control and Prevention. (2021). National Diabetes Statistics Report, 2021. Retrieved from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.Pdf
  8. Trayhurn, P. (2005). Adipose tissue in obesity—an inflammatory issue. Endocrinology, 146(3), 1003-1005.
  9. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation, 106(2), 171-176.
  10. Locke, A. E., Kahali, B., Berndt, S. I., Justice, A. E. E., Pers, T. H., Day, F. R., … & Speliotes, E. K. (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature, 518(7538), 197-206.
  11. Hill, J. O., Wyatt, H. R., & Peters, J. C. (2012). Energy balance and obesity. Circulation, 126(1), 126-132.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401553/
  12. Drewnowski, A., & Specter, S. E. (2004). Poverty and obesity: the role of energy density and energy costs. The American Journal of Clinical Nutrition, 79(1), 6-16.
  13. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346(6), 393-403.
  14. Story, M., Kaphingst, K. M., Robinson-O’Brien, R., & Glanz, K. (2008). Creating healthy food and eating environments: policy and environmental approaches. Annual Review of Public Health, 29, 253-272.
  15. Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C., & Hu, F. B. (2011). Changes in diet and lifestyle and long-term weight gain in women and men. The New England Journal of Medicine, 364(25), 2392-2404.
  16. Sallis, J. F., Floyd, M. F., Rodríguez, D. A., & Saelens, B. E. (2012). Role of built environments in physical activity, obesity, and cardiovascular disease. Circulation, 125(5), 729-737.
  17. Kahn,E. B., Ramsey, L. T., Brownson, R. C., Heath, G. W., Howze, E. H., Powell, K. E., … & Corso, P. (2002). The effectiveness of interventions to increase physical activity: a systematic review. American Journal of Preventive Medicine, 22(4), 73-107.
  18. US Preventive Services Task Force. (2015). Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 163(11), 861-868.
  19. Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., … & Tuomilehto, J. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet, 368(9548), 1673-1679.https://pubmed.ncbi.nlm.nih.gov/17098085/
  20. American Diabetes Association. (2021). Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S1-S232.
  21. Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., … & Still, C. D. (2015). Pharmacological management of obesity: an endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(2), 342-362.
  22. Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G., Zimmet, P. Z., … & Dixon, J. B. (2016). Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care, 39(6), 861-877.
  23. Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., … & Bornstein, S. R. (2015). Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up of an open-label, single-center, randomized controlled trial. The Lancet, 386(9997), 964-973.
  24. Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., … & Yancy, W. S. (2019). Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care, 42(5), 731-754.
  25. Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., … & Tate, D. F. (2016). Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care, 39(11), 2065-2079.
  26. American Diabetes Association. (2021). Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S53-S72.
  27. Chew, B. H., Vos, R. C., Metzendorf, M. I., Scholten, R. J., & Rutten, G. E. (2018). Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. The Cochrane Database of Systematic Reviews, 9(9), CD011469.
  28. Hawley, K. L., Roberto, C. A., Bragg, M. A., Liu, P. J., Schwartz, M. B., & Brownell, K. D. (2013). The science on front-of-package food labels. Public Health Nutrition, 16(3), 430-439.
  29. World Health Organization. (2010). Set of recommendations on the marketing of foods and non-alcoholic beverages to children. Geneva: World Health Organization.
  30. Wright, A., Smith, K. E., & Hellowell, M. (2017). Policy lessons from health taxes: a systematic review of empirical studies. BMC Public Health, 17(1), 583.
  31. Sallis, JF., Floyd, M. F., Rodríguez, D. A., & Saelens, B. E. (2012). Role of built environments in physical activity, obesity, and cardiovascular disease. Circulation, 125(5), 729-737.
  32. Larson, N. I., Story, M. T., & Nelson, M. C. (2009). Neighborhood environments: disparities in access to healthy foods in the U.S. American Journal of Preventive Medicine, 36(1), 74-81.
  33. Alley, D. E., Asomugha, C. N., Conway, P. H., & Sanghavi, D. M. (2016). Accountable Health Communities—Addressing Social Needs through Medicare and Medicaid. New England Journal of Medicine, 374(1), 8-11.
  34. Story, M., Kaphingst, K. M., Robinson-O’Brien, R., & Glanz, K. (2008). Creating healthy food and eating environments: policy and environmental approaches. Annual Review of Public Health, 29, 253-272.
  35. Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003). Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA, 289(1), 76-79.
  36. Marcolino, M. S., Oliveira, J. A. Q., D’Agostino, M., Ribeiro, A. L., Alkmim, M. B. M., & Novillo-Ortiz, D. (2018). The impact of mHealth interventions: systematic review of systematic reviews. JMIR mHealth and uHealth, 6(1), e23.
  37. Wagner, E. H., Austin, B. T., & Von Korff, M. (1996). Organizing care for patients with chronic illness. The Milbank Quarterly, 74(4), 511-544.
  38. Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002). Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care, 25(7), 1159-1171.
  39. Woolf, S. H. (2008). The meaning of translational research and why it matters. JAMA, 299(2), 211-213.
  40. Piwowar, H. A., Becich, M. J., Bilofsky, H., & Crowley, R. S. (2008). Towards a data sharing culture: recommendations for leadership from academic health centers. PLoS Medicine, 5(9), e183.
  41. Ebrahim, S., & Taylor, F. C. (2005). Combating the global burden of cardiovascular disease. International Journal of Epidemiology, 34(4), 731-732.
  42. Kumanyika, S. K., & Obarzanek, E. (2003). Pathways to obesity prevention: report of a National Institutes of Health workshop. Obesity Research, 11(10), 1263-1274.
  43. Levine, R., & Kuczynski, D. (2009). Global nutrition institutions: Is there an app for that? The Lancet, 374(9706), 1897-1898.
  44. Torgan, C. E. (2010). The mHealth summit: local & global converged. Journal of Mobile Technology in Medicine, 1(1), 37-38.

Related News